← Leaderboards
Gabriela S Dveksler
Henry M. Jackson Fdn For The Adv Mil/Med
$5,192,209
Attributed
$5,192,209
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $612.1K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,192,209 · 7
By mechanism
R01$3,137,426 · 2
R21$1,659,929 · 4
R29$394,854 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Glycoproteins”
- Dennis R. Burton · Scripps Research Institute$211,788,189
- Joseph G Sodroski · University Of Pennsylvania$47,423,604
- Kartik Chandran · Albert Einstein College Of Medicine$41,665,810
- Erica Ollmann Saphire · Scripps Research Institute$32,718,575
- Robert F Garry · Scripps Research Institute, The$32,430,244
- James E Crowe · Vanderbilt University Medical Center$32,099,289
Research focus
GlycoproteinsPregnancyPlacentaCytokineMacrophageReceptorMothersCellsProteinsBlood CirculationFetusRecombinantsImmune SystemFamilyImmune ResponseBiologicalSuccessImmuneProtein FamilyMemberBaseMaternal-Fetal ExchangeLigandsDesign
Grant awards (22)
Not all members of the pregnancy-specific glycoprotein family are created equal$227,899
R21 · FY2023 · AI · contact PI
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System$228,744
R21 · FY2022 · AI · contact PI
Not all members of the pregnancy-specific glycoprotein family are created equal$189,916
R21 · FY2022 · AI · contact PI
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System$190,621
R21 · FY2021 · AI · contact PI
Therapeutic potential of PSG1 administration in GVHD$231,012
R21 · FY2017 · AI · contact PI
Therapeutic potential of PSG1 administration in GVHD$192,510
R21 · FY2016 · AI · contact PI
Pregnancy specific glycoprotein 1 activates transforming growth factor beta$211,620
R21 · FY2013 · AI · contact PI
Pregnancy specific glycoprotein 1 activates transforming growth factor beta$187,607
R21 · FY2012 · AI · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$268,821
R01 · FY2010 · HD · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$115,425
R01 · FY2010 · HD · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$271,536
R01 · FY2009 · HD · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$271,536
R01 · FY2008 · HD · contact PI
Immunomodulation by Pregnancy Specific Glycoprotein 17$317,238
R01 · FY2007 · AI · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$277,078
R01 · FY2007 · HD · contact PI
Immunomodulation by Pregnancy Specific Glycoprotein 17$326,713
R01 · FY2006 · AI · contact PI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$285,354
R01 · FY2006 · HD · contact PI
Immunomodulation by Pregnancy Specific Glycoprotein 17$334,575
R01 · FY2005 · AI
Immunomodulation by Pregnancy Specific Glycoprotein 17$334,575
R01 · FY2004 · AI
Immunomodulation by Pregnancy Specific Glycoprotein 17$334,575
R01 · FY2003 · AI
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$131,618
R29 · FY2002 · HD
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$131,618
R29 · FY2001 · HD
FUNCTIONS OF PREGNANCY SPECIFIC GLYCOPROTEINS$131,618
R29 · FY2000 · HD